Evidence map›Paper›PMID 31955151›Full record

ArticleAging2020

Dasatinib plus quercetin prevents uterine age-related dysfunction and fibrosis in mice.

Marcelo B Cavalcante, Tatiana D Saccon, Allancer D C Nunes, James L Kirkland, Tamara Tchkonia, Augusto Schneider, Michal M Masternak

Registry-linked trialAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04946383 (The Safety and Effectivness of Quercetin and Dasatinib on the Epigenetic Aging Rates in Healthy Individuals), which is not on this map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04946383 phase2unknown statusnot on this map

The Safety and Effectivness of Quercetin and Dasatinib on the Epigenetic Aging Rates in Healthy Individuals

TypeinterventionalSponsorTruDiagnosticRan2020 to 2022Enrolled25ConditionsAgingArmsDasatinib plus Quercetin
3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Uterine Aging and Reproduction: Dealing with a Puzzle Biologic Topic.International journal of molecular sciences · 2023
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marcelo B CavalcanteBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.
Tatiana D SacconBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.
Allancer D C NunesBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.
James L KirklandRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN 55905, USA.
Tamara TchkoniaRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN 55905, USA.
Augusto SchneiderFaculdade de Nutrição, Universidade Federal de Pelotas, Pelotas 96010-610, RS, Brazil.
Michal M MasternakBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.

Funding

Targeting Cellular Senescence to Extend HealthspanP01AG062413 · NIA · MAYO CLINIC ROCHESTER · PI Sundeep Khosla, Nathan K LeBrasseur · 2019 to 2026
$28.7M
Effect of Aging on Preadipocyte DifferentiationR37AG013925 · NIA · MAYO CLINIC ROCHESTER · PI KIRKLAND, JAMES L. · 2016 to 2025
$6.6M
Role of adipose tissue cellular composition on healthy metabolismR15AG059190 · NIA · UNIVERSITY OF CENTRAL FLORIDA · PI MASTERNAK, MICHAL MATEUSZ · 2018 to 2020
$444k
Senescence cells as a source of pro-aging miR-146aR56AG061414 · NIA · UNIVERSITY OF CENTRAL FLORIDA · PI KIRKLAND, JAMES L., MASTERNAK, MICHAL MATEUSZ · 2019 to 2019
$406k
Role of GH/IGF1 signaling pathway on pro-longevity miRNAsR03AG059846 · NIA · UNIVERSITY OF CENTRAL FLORIDA · PI MASTERNAK, MICHAL MATEUSZ · 2018 to 2019
$298k
NIA NIH HHS P01 AG062413NIA NIH HHS R03 AG059846NIA NIH HHS R15 AG059190NIA NIH HHS R37 AG013925NIA NIH HHS R56 AG061414
6 · The paper itself

Abstract

The uterine fibrosis contributes to gestational outcomes. Collagen deposition in the uterus is related to uterine aging. Senolytic therapies are an option for reducing health complications related to aging. We investigated effects of aging and the senolytic drug combination of dasatinib plus quercetin (D+Q) on uterine fibrosis. Forty mice, 20 young females (03-months) and 20 old females (18-months), were analyzed. Young (Y) and old (O) animals were divided into groups of 10 mice, with one treatment (T) group (YT and OT) and another control © group (YC and OC). Comparative analysis of

Indexed as

AgingAnimalsAntioxidantsDasatinibDrug Therapy, CombinationFemaleFibrosisMiceProtein Kinase InhibitorsQuercetinUterine DiseasesUterusAntioxidantsDasatinibProtein Kinase InhibitorsQuercetinagingmiRNAmRNAsenolyticsuterine fibrosis

Identifiers

PMID31955151
PMCPMC7041753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.